Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H35ClN2O5S.ClH |
Molecular Weight | 475.471 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.[H][C@@]1(O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O)[C@H](NC(=O)[C@@H]2C[C@@H](CCCCC)CN2)[C@H](C)Cl
InChI
InChIKey=YQEJFKZIXMSIBY-ODKHAUALSA-N
InChI=1S/C19H35ClN2O5S.ClH/c1-4-5-6-7-11-8-12(21-9-11)18(26)22-13(10(2)20)17-15(24)14(23)16(25)19(27-17)28-3;/h10-17,19,21,23-25H,4-9H2,1-3H3,(H,22,26);1H/t10-,11+,12-,13+,14-,15+,16+,17+,19+;/m0./s1
Molecular Formula | C19H35ClN2O5S |
Molecular Weight | 439.01 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Mirincamycin, a protein biosynthesis inhibitor was studied as an antibacterial agent. It was shown that mirincamycin could be promising candidate in the therapy and prophylaxis of multidrug-resistant falciparum malaria. Moreover, in combination with 4 or 8-aminoquinolines it could be used for the treatment and relapse prevention of vivax malaria. In addition, was studied the anti-relapse activity of mirincamycin in the Plasmodium cynomolgi sporozoite-infected Rhesus monkey model. However, the negative P. cynomolgi hypnozoite data indicates that mirincamycin is unlikely to have potential as a clinical anti-relapse agent.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Enhancement of the curative activity of primaquine by concomitant administration of mirincamycin. | 1985 Feb |
|
In vitro activity of mirincamycin (U24729A) against Plasmodium falciparum isolates from Gabon. | 2010 Jan |
|
Absolute bioavailability of cis-mirincamycin and trans-mirincamycin in healthy rhesus monkeys and ex vivo antimalarial activity against Plasmodium falciparum. | 2011 Dec |
|
Mirincamycin, an old candidate for malaria combination treatment and prophylaxis in the 21st century: in vitro interaction profiles with potential partner drugs in continuous culture and field isolates. | 2014 Jun 10 |
|
Anti-relapse activity of mirincamycin in the Plasmodium cynomolgi sporozoite-infected Rhesus monkey model. | 2014 Oct 17 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:07:11 GMT 2023
by
admin
on
Fri Dec 15 15:07:11 GMT 2023
|
Record UNII |
B433NEX5J7
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL2110945
Created by
admin on Fri Dec 15 15:07:11 GMT 2023 , Edited by admin on Fri Dec 15 15:07:11 GMT 2023
|
PRIMARY | |||
|
76960024
Created by
admin on Fri Dec 15 15:07:11 GMT 2023 , Edited by admin on Fri Dec 15 15:07:11 GMT 2023
|
PRIMARY | |||
|
B433NEX5J7
Created by
admin on Fri Dec 15 15:07:11 GMT 2023 , Edited by admin on Fri Dec 15 15:07:11 GMT 2023
|
PRIMARY | |||
|
C174631
Created by
admin on Fri Dec 15 15:07:11 GMT 2023 , Edited by admin on Fri Dec 15 15:07:11 GMT 2023
|
PRIMARY | |||
|
38740-71-5
Created by
admin on Fri Dec 15 15:07:11 GMT 2023 , Edited by admin on Fri Dec 15 15:07:11 GMT 2023
|
ALTERNATIVE | |||
|
8063-91-0
Created by
admin on Fri Dec 15 15:07:11 GMT 2023 , Edited by admin on Fri Dec 15 15:07:11 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |